FDA Inspection 1030039 — Indivior, Inc.

Indivior, Inc. — FEI 3012118007

The FDA completed an inspection of Indivior, Inc. on October 19, 2017 in North Chesterfield, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 19, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Chesterfield, VA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors